Australia markets closed

Sangamo Therapeutics Inc (GBY.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.5309+0.0053 (+1.01%)
As of 08:05AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
18,756
176,232
111,299
110,701
118,192
-
Operating expenses
Research development
206,732
234,057
249,898
230,819
180,647
-
Selling general and administrative
54,798
61,167
62,682
63,219
67,097
-
Total operating expenses
261,530
295,224
312,580
294,038
247,744
-
Operating income or loss
-242,774
-118,992
-201,281
-183,337
-129,552
-
Total other income/expenses net
-100,791
-155,013
-
-
-
-
Income before tax
-333,221
-262,903
-191,849
-177,991
-120,777
-
Income tax expense
-5,168
-5,072
429
306
345
-
Income from continuing operations
-328,053
-257,831
-192,278
-178,297
-121,122
-
Net income
-328,053
-257,831
-192,278
-178,286
-120,996
-
Net income available to common shareholders
-328,053
-257,831
-192,278
-178,286
-120,996
-
Basic EPS
-1.25
-
-1.25
-1.23
-0.90
-0.85
Diluted EPS
-1.25
-
-1.25
-1.23
-0.90
-0.85
Basic average shares
154,345
-
154,345
144,568
134,449
112,114
Diluted average shares
154,345
-
154,345
144,568
134,449
112,114